Invitris Analysis: $125K Raised

What is Invitris?

Invitris develops synthetic proteins using a universal platform technology, focusing on human therapeutics and industrial applications with high yields and purity.

Product Features & Capabilities

• human therapeutics, industrial applications, synthetic proteins, phages, tailocins, endolysins, neoantigens, vaccines, antibodies, toxic proteins (nucleases, proteases), prokaryotic cell-free expression systems, eukaryotic cell-free expression systems, applications in human health, agriculture, anim

How much Invitris raised

Who are the founders of Invitris

Investors